Drugs / antimony
last change Sep 2007 re-read 2 minutes ago

antimony

Small molecule

Developed for
cutaneous leishmaniasis
Investigated by
AB Foundation

Trials 1 · a red edge is where a trial was stopped

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00233545 Sep 2005 → Sep 2007 cutaneous leishmaniasis AB Foundation Completed No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as antimony ClinicalTrials.gov intervention name — accepted as the source's own label NCT00233545
Known as Antimony black ChEMBL registry synonym — accepted as the source's own label CHEMBL4297652
Known as Antimony element ChEMBL registry synonym — accepted as the source's own label CHEMBL4297652
Known as Antimony, elemental ChEMBL registry synonym — accepted as the source's own label CHEMBL4297652
Known as C.I. 77050 ChEMBL registry synonym — accepted as the source's own label CHEMBL4297652
Known as Metallic antimony ChEMBL registry synonym — accepted as the source's own label CHEMBL4297652
Known as Prepared metallic antimony ChEMBL registry synonym — accepted as the source's own label CHEMBL4297652
Known as Stibium metallicum ChEMBL registry synonym — accepted as the source's own label CHEMBL4297652
Modality Small molecule CHEMBL4297652